Fiocruz partners with Angolan university

10 July 2023
fiocruz_brazil_large

Brazil’s Oswaldo Cruz Institute (IOC/Fiocruz) and the Agostinho Neto University (UAN), in Luanda, Angola), have signed a memorandum of understanding for future partnerships in teaching and research between the institutions

Representing another step in the search for closer ties with African institutions, the partnership aims at mutual collaboration in the following areas: neglected tropical diseases, with emphasis on malaria and tuberculosis; communicable diseases; arboviruses; antimicrobial resistance (AMR); HIV; climate and health; maternal, child and reproductive health; among others. The memorandum of understanding signed between the institutions is valid for five years.

“It is part of the institutional cooperation policy to strengthen technical-scientific partnerships with countries in the southern hemisphere, especially Portuguese-speaking countries. The IOC's focus is on contributing to the training of human resources in these places. We can help them face public health problems linked, especially, to transmissible diseases”, commented he Institute's institutional cooperation coordinator, Anna Cristina Calçada Carvalho.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical